Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Future Medicinal Chemistry|July 21, 2025
Exploring norfloxacin analogs in combating antimicrobial resistance: design, mechanistic insights and structure activity relationshipAanchal Khanna, Karanvir Singh, Jyoti, et al.
Applied Microbiology and Biotechnology|February 4, 2016
Cell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureusHarmandeep Kaur Randhawa, Ankur Gautam, Minakshi Sharma, et al.
Bioorganic & Medicinal Chemistry|July 1, 2019
Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybridsHarbinder Singh, Jatinder Vir Singh, Kavita Bhagat, et al.
Archiv Der Pharmazie|January 10, 2024
Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studiesHarmandeep Kaur Gulati, Aanchal Khanna, Nitish Kumar, et al.
Natural Product Research|October 10, 2022
Shikonin derivatives as potent xanthine oxidase inhibitors: in-vitro studyNitish Kumar, Ankita Rajput, Harmandeep Kaur, et al.
Diabetes|December 14, 2020
Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker-Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19Sri Nagarjun Batchu, Harmandeep Kaur, Veera Ganesh Yerra, et al.
Molecular Diversity|January 22, 2024
Antidiabetic potential of thiazolidinedione derivatives with efficient design, molecular docking, structural activity relationship, and biological activity: an update review (2021-2023)Anchal Sharma, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Frontiers in Chemistry|December 29, 2023
Valorization of grape (Vitis vinifera) leaves for bioactive compounds: novel green extraction technologies and food-pharma applicationsJyoti Singh, Prasad Rasane, Rajdeep Kaur, et al.
Nature Communications|April 8, 2015
Quantitative analysis of the TNF-α-induced phosphoproteome reveals AEG-1/MTDH/LYRIC as an IKKβ substrateRamesh K Krishnan, Hendrik Nolte, Tianliang Sun, et al.
Expert Opinion on Therapeutic Patents|October 3, 2022
Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001-2021)Kavita Bhagat, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Pageof 8